Structure Therapeutics (GPCR) Assets Average (2023 - 2026)

Structure Therapeutics' Assets Average history runs 4 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• On a quarterly basis, Assets Average rose 74.7% year-over-year to $1.5 billion in Q1 2026; TTM through Mar 2026 was $1.5 billion, a 74.7% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 79.54% from the prior year.
• Assets Average grew to $1.5 billion in Q1 2026 per GPCR's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Assets Average topped out at $1.5 billion in Q1 2026 and bottomed at $172.6 million in Q1 2023.
• The 4-year median for Assets Average is $824.3 million (2025), against an average of $716.8 million.
• Across the five-year window, Assets Average surged 321.77% in 2024 and retreated 12.32% in 2025, its largest moves.
• Year by year, Assets Average stood at $349.2 million in 2023, then soared by 162.97% to $918.3 million in 2024, then jumped by 31.56% to $1.2 billion in 2025, then climbed by 27.98% to $1.5 billion in 2026.
• Per Business Quant, the three latest GPCR Assets Average figures stand at $1.5 billion (Q1 2026), $1.2 billion (Q4 2025), and $824.3 million (Q3 2025).